Search results
Results from the WOW.Com Content Network
[4] [12] [14] [22] Roughly 50% of newborns of GBS-colonized mothers are also GBS-colonized and (without prevention measures) 1-2% of these newborns will develop GBS-EOD. [14] [24] The most common clinical syndromes of GBS-EOD are sepsis, pneumonia, and (less commonly) meningitis. Pneumonia and sepsis are frequently seen together or sequentially.
Roughly 50% of newborns to GBS colonized mothers are also GBS colonized and (without prevention measures) 1–2% of these newborns will develop EOD. [32] In the past, the incidence of EOD ranged from 0.7 to 3.7 per thousand live births in the US [3] and from 0.2 to 3.25 per thousand in Europe. [18]
Played a part in causing the 2003 RCOG risk-based guidelines on the prevention of early-onset group B Strep infection, and continues to campaign for improved guidelines and awareness in medical professionals. [11] Raised significant public awareness of group B Strep and the impact a group B Strep infection can have on newborn babies if not ...
A GBS vaccine is currently being tested but not currently available. Vaccination is estimated to being able to prevent 4% of GBS infections for preterm births and 60–70% for neonatal GBS infections in the US. The projected benefits of maternal vaccination is the prevention of 899 cases of GBS disease and 35 deaths among infants.
Intrapartum prophylaxis is a strategy for "the secondary prevention of early-onset GBS disease in newborns" that could lead to EOS. [33] The Sepsis Risk Calculator (SRS) is meant to be another clinical measure that physicians can use in conjunction with physical examination. [22]
GBS bacteriuria during this pregnancy; History of GBS disease in a previous infant; Intrapartum fever (≥38 °C) Preterm labour (<37 weeks) Prolonged rupture of membranes (>18 hours) This protocol results in the administration of intrapartum antibiotics to 15–20% of pregnant women and the prevention of 65–70% of cases of early onset GBS ...
Streptococcus canis is a group G beta-hemolytic species of Streptococcus. [1] It was first isolated in dogs, giving the bacterium its name. These bacteria are characteristically different from Streptococcus dysgalactiae, which is a human-specific group G species that has a different phenotypic chemical composition.
Erysipelas (/ ˌ ɛ r ə ˈ s ɪ p ə l ə s /) is a relatively common bacterial infection of the superficial layer of the skin (upper dermis), extending to the superficial lymphatic vessels within the skin, characterized by a raised, well-defined, tender, bright red rash, typically on the face or legs, but which can occur anywhere on the skin.